Neocis gets FDA nod for new Yomi component

2020 02 24 17 44 7728 Clearance Stamp 400

Robotic dental implant surgery developer Neocis has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new component for use with its Yomi technology.

Yomi provides robot-assisted guidance relative to preoperative plans based on CT scans and can be used with conebeam CT scanners installed in dental offices. The new component reduces the CT scanner field-of-view requirements for Yomi, which Neocis believes will broaden the market for adoption of its robot-assisted dental surgery system.

Page 1 of 659
Next Page